TrademarkDir
HETLIOZ LQ
LIVE

Serial Number

90288233

Owner

Vanda Pharmaceuticals Inc.

Attorney

Jayme M. Torelli

First Use Date

Aug 28, 2020

Filing Date

Oct 29, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

HETLIOZ LQ Trademark

Serial Number: 90288233 • Registration: 6828605

HETLIOZ LQ is a trademark filed by Vanda Pharmaceuticals Inc. on October 29, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Vanda Pharmaceuticals Inc. (104 trademarks)

Suite 300
Rockville, MD 20850

Entity Type: 03

Trademark Details

Filing Date

October 29, 2020

Registration Date

August 23, 2022

First Use Anywhere

August 28, 2020

First Use in Commerce

December 1, 2020

Published for Opposition

May 11, 2021

Goods & Services

Pharmaceutical preparations, in liquid form and containing tasimelteon, for use in the treatment of diseases and disorders of the central nervous system, diseases and disorders having an impact on the central nervous system, diseases and disorders having a central nervous system manifestation, diseases and disorders of the circadian rhythm, diseases and disorders having an impact on circadian rhythm, and diseases and disorders having a circadian rhythm manifestation

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 23, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 23, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 21, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 20, 2022 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 28, 2022 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Jun 27, 2022 SUPC
SOU EXTENSION 2 GRANTED
Jun 27, 2022 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 27, 2022 AITU
USE AMENDMENT FILED
Jun 17, 2022 IUAF
SOU EXTENSION 2 FILED
Jun 17, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 17, 2022 EEXT
TEAS STATEMENT OF USE RECEIVED
Jun 17, 2022 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 29, 2021 EXRA
SOU EXTENSION 1 GRANTED
Dec 27, 2021 EX1G
SOU EXTENSION 1 FILED
Dec 27, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 27, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 6, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 11, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 11, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 21, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 5, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 5, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 5, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 5, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 5, 2021 CNEA
ASSIGNED TO EXAMINER
Mar 30, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 23, 2020 NWOS
NEW APPLICATION ENTERED
Nov 2, 2020 NWAP

Related Trademarks

More from this Owner

NEREUS 85MG (TRADIPITANT) CAPSULES logo

NEREUS 85MG (TRADIPITANT) CAPSULES

NEREUS (TRADIPITANT) logo

NEREUS (TRADIPITANT)

Trademark logo

Serial #99839209

NEREUS (TRADIPITANT) CAPSULES logo

NEREUS (TRADIPITANT) CAPSULES

DELOSRX

DELOSRX

QUIMILZA

QUIMILZA